Piper Sandler & Co’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Piper Sandler & Co’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,003	Closed	-$257K	–	15
2023 Q2	$257K	Hold	25,003	–	–	0.27%	14
2023 Q1	$253K	Hold	25,003	–	–	0.17%	22
2022 Q4	$248K	Hold	25,003	–	–	0.26%	21
2022 Q3	$243K	Hold	25,003	–	–	0.2%	26
2022 Q2	$242K	Hold	25,003	–	–	0.22%	28
2022 Q1	$244K	Buy	+25,003	New	+$241K	0.18%	19

Piper Sandler & Co's DALS Position: Q3 2023 in Review

Piper Sandler & Co sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 25,003 shares — an estimated $257K sold.

Piper Sandler & Co first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $257K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Piper Sandler & Co reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Piper Sandler & Co sold 25,003 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $257K.
Piper Sandler & Co first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 6 quarters.
Piper Sandler & Co's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $257K in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Piper Sandler & Co's 13F filing for Q3 2023, filed 14 Nov 2023.